Co-Authors
This is a "connection" page, showing publications co-authored by Meletios Dimopoulos and Theodoros Sergentanis.
Connection Strength
0.792
-
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors. Eur J Intern Med. 2021 07; 89:87-96.
Score: 0.236
-
Hematological findings and complications of COVID-19. Am J Hematol. 2020 07; 95(7):834-847.
Score: 0.221
-
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19. Hemasphere. 2020 Jun; 4(3):e409.
Score: 0.221
-
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study. Microorganisms. 2020 Nov 28; 8(12).
Score: 0.057
-
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19. Thromb Haemost. 2020 Dec; 120(12):1680-1690.
Score: 0.057